Inclusion Criteria:  Any individual with a confirmed or suspected diagnosis of MGUS, SMM, or MM.  Exclusion Criteria:  Patients under the age of 18 Patients with active symptomatic myeloma at diagnosis Patients with no evidence of MGUS, sMM or MM Patients with rapidly rising paraprotein or serum free light chains suggestive of progressive disease at time of diagnosis or inclusion into study